&Partners’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Sell
11,073
-1,670
-13% -$88.1K ﹤0.01% 1742
2026
Q1
$672K Sell
12,743
-338
-3% -$17.8K ﹤0.01% 1528
2025
Q4
$691K Sell
13,081
-755
-5% -$40K ﹤0.01% 1440
2025
Q3
$735K Buy
13,836
+3,264
+31% +$173K ﹤0.01% 1239
2025
Q2
$560K Buy
+10,572
New +$557K ﹤0.01% 1298

Other funds holding CLOI

&Partners's CLOI Position: Q2 2026 in Review

&Partners reduced its VanEck CLO ETF (CLOI) stake by 13% in Q2 2026, selling an estimated $88.1K and leaving 11,073 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1742.

&Partners first reported a position in CLOI in Q2 2025 and has held it in 5 quarters since. The position peaked at $735K in Q3 2025. 198 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • &Partners held 11,073 shares of VanEck CLO ETF worth $586K as of Q2 2026.
  • &Partners sold 1,670 VanEck CLO ETF shares in Q2 2026, an estimated $88.1K.
  • VanEck CLO ETF made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1742 holding.
  • &Partners first reported a position in VanEck CLO ETF in Q2 2025 and has held it in 5 quarters since.
  • &Partners's VanEck CLO ETF position peaked at $735K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.